Moira Bode

Prof. Moira Bode

orcid

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 February 2020 in Chemical Science
Verified
Journal Article
Open access
PDF file
Roger SheldonRoger Sheldon
Roger Sheldon
DBDean Brady
Dean Brady
MBMoira Bode
Moira Bode
Enzymes are excellent catalysts that are increasingly being used in industry and academia. This Perspective provides a general and practical guide to enzymes and their synthetic potential, primarily aimed at synthetic organic chemists.

1 February 2022 in Current Opinion in Green and Sustainable Chemistry
Verified
Journal Article
Closed access
Roger SheldonRoger Sheldon
Roger Sheldon
MBMoira Bode
Moira Bode
SAStephanie G. Akakios
Stephanie G. Akakios

1 July 2011 in Bioorganic & Medicinal Chemistry
Verified
Journal Article
Closed access
MBMoira Bode
Moira Bode
DGDavid Gravestock
David Gravestock
SMSimon S. Moleele
Simon S. Moleele
CWChris van der Westhuyzen
Chris van der Westhuyzen
SPStephen C. Pelly
Stephen C. Pelly
LNLindiwe A. Nkabinde
Lindiwe A. Nkabinde

1 September 1991 in Tetrahedron Letters
Verified
Journal Article
Closed access
MBMoira Bode
Moira Bode
PKPerry T. Kaye
Perry T. Kaye

1 January 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
JDJean Dam
Jean Dam
ZIZeenat Ismail
Zeenat Ismail
TKTaurai Kurebwa
Taurai Kurebwa
NGNadia Gangat
Nadia Gangat
LHLeonie Harmse
Leonie Harmse
CKCharles B. de Koning
Charles B. de Koning

22 May 2012 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
CRChevonne Reynolds
Chevonne Reynolds
CKCharles B. de Koning
Charles B. de Koning
SPStephen C. Pelly
Stephen C. Pelly
WOWillem A. L. van Otterlo
Willem A. L. van Otterlo
MBMoira Bode
Moira Bode
The human immunodeficiency virus (HIV) causes AIDS (acquired immune deficiency syndrome), a disease in which the immune system progressively deteriorates, making sufferers vulnerable to all manner of opportunistic infections. Currently, world-wide there are estimated to be 34 million people living with HIV, with the vast majority of these living in sub-Saharan Africa. Therefore, an important research focus is development of new drugs that can be used in the treatment of HIV/AIDS. This review gives an overview of the disease and addresses the drugs currently used for treatment, with specific emphasis on new developments within the class of allosteric non-nucleoside reverse transcriptase inhibitors (NNRTIs).